Schedule 13G ownership disclosure

BIOSTEM TECHNOLOGIES INC

Common Stock, $0.001 par value (the "Common Stock") · CUSIP: 090684200

Event date: 2026-09-30

Filing-level shares
3,854,452.00
Percent of class
18.4%
  • Andrew Van Vurst

    Shares: 3,854,452.00 · Class: 18.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-26-118034
Form type
SCHEDULE 13G
Filer
SMITH-VAN VURST ANDREW
CIK
CIK 2147206
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub